Upstate Active Clinical Trials
Study Title:A Phase II Randomized Trial of Lenalidomide (NSC # 703813, IND # 70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytoma and Optic Pathway Gliomas
What is the purpose of the study?Treatment study to look at how well sunitinib malate works in treating younger patients with recurrent, refractory, or progressive malignant glioma or ependymoma.
Upstate Institutional Review Board (IRB) Number:448389
Patient Age Group:Children
Principal Investigator:Melanie A Comito
Who can I contact for more information?
Name: Beatriz Kovar